They are obliged to report to us. I can't tell you the technical details of that, but some companies do better than others.
If you asked a large drug manufacturer why they aren't investing more in research and development in Canada they may not tell you, or they may tell you it's because they find the regulatory environment on prices too oppressive. In other words, if you got rid of the PMPRB they would charge what they want and invest relatively more here.